medRxiv PreprintsInternational17 November 2026
Cervicovaginal metabolites mediate the relationship between vaginal microbiota and risk for Chlamydia trachomatis infection
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Background: Chlamydia trachomatis (CT) remains the most prevalent bacterial sexually transmitted infection and a cause of adverse reproductive outcomes. Epidemiologic studies describe bacterial vaginosis (BV) as a major risk factor for CT infection. Emerging data suggest that BV-associated bacteria and their metabolites contribute to CT susceptibility. Here, we measured the role of specific bacteria in incident CT and evaluated a hypothesized causal role between the vaginal microbiota, its metabolites, and CT risk. Methods: We conducted a nested case-control study of Kenyan women who engage in
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.